查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1577452

Iodine-131 同位素市場：按應用、最終用戶、形式、治療程序、患者人口統計 - 2025-2030 年全球預測

Iodine-131 Isotope Market by Application (Agricultural, Industrial, Medical), End User (Agricultural Sector, Hospitals and Clinics, Pharmaceutical Companies), Form, Therapeutic Procedures, Patient Demographics - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

碘131同位素市場2023年估值為52億美元，預計到2024年將達到55.2億美元，複合年成長率為6.48%，預計到2030年將達到80.7億美元。

Iodine-131 是一種放射性同位素，廣泛用於醫療應用，特別是用於核子醫學的診斷和治療目的。由於其能夠選擇性破壞組織，因此可用於治療甲狀腺疾病，例如甲狀腺功能亢進症和某些類型的甲狀腺癌。在能源領域，Iodine-131 也用作水力壓裂和逆流診斷的示踪劑。碘131市場的推動因素包括全球甲狀腺疾病盛行率的不斷上升、人們對核醫學的認知和採用的提高以及放射性製藥技術的進步。成長的推動因素是醫療基礎設施投資的增加和老年人口的增加，而老年人口更容易患甲狀腺疾病。此外，對微創治療的需求不斷成長也有助於市場擴張。最近的商業機會包括靶向放射性藥物治療的技術創新，這些創新允許將碘 131 用於治療其他癌症類型，同時改進遞送機制以提高療效，並減少副作用。然而，嚴格的法律規範、高製造成本以及由於材料的放射性而需要特殊處理和處置程序等挑戰可能會阻礙成長前景。供應鏈限制以及生產中對一致品質標準的需求也產生了限制。為了抓住市場機遇，研究機構和放射性製藥公司之間開拓策略合作非常重要。需要技術創新的領域包括研究碘131的新載體分子、提高劑量準確性以及擴大甲狀腺相關疾病以外的應用範圍。市場是動態的，其特點是技術快速進步和不斷變化的治療需求。這些共同強調了持續研究投資和監管合規對於維持競爭優勢和市場滲透的重要性。

主要市場統計
基準年[2023] 52億美元
預測年份 [2024] 55.2億美元
預測年份 [2030] 80.7億美元
複合年成長率（%） 6.48%

市場動態：快速發展的碘 131 同位素市場的關鍵市場洞察

碘 131 同位素市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大核子醫學成像技術在使用碘 131 診斷和治療各種癌症的應用
    • 加強醫療保健和研究機構之間的合作，促進碘 131 的治療用途
    • 透過將碘131同位素應用擴展到腫瘤學以外的醫學領域來促進市場成長
  • 市場限制因素
    • 發展中地區缺乏先進的醫療設施和訓練有素的碘 131 應用專業人員
  • 市場機會
    • 碘 131 同位素在獸醫學和動物健康領域的成長潛力研究
    • 新興市場甲狀腺疾病治療方案中碘 131 同位素採用的評估
    • 探討碘 131 同位素在創新核醫治療的應用
  • 市場挑戰
    • 與替代診斷和治療同位素的競爭

波特五力：駕馭碘 131 同位素市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解碘 131 同位素市場的外部影響

外部宏觀環境因素在影響碘 131 同位素市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解碘131同位素市場的競爭狀況

對碘 131 同位素市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣碘 131 同位素市場供應商的績效評估

FPNV定位矩陣是評估碘131同位素市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃碘 131 同位素市場的成功之路

碘 131 同位素市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 使用碘 131 擴大採用核成像技術來診斷和治療各種癌症
      • 加強醫療保健和研究機構之間的合作，推進碘 131 的治療用途
      • 碘 131 同位素的應用範圍從腫瘤學擴展到其他醫學領域，推動市場成長
    • 抑制因素
      • 發展中地區缺乏先進的醫療設施和訓練有素的專業人員來應用碘 131
    • 機會
      • 碘131同位素在獸醫學和動物健康領域的成長潛力研究
      • 評估新興市場甲狀腺疾病治療通訊協定中碘 131 同位素的採用情況
      • 考慮在創新核子醫學治療中使用碘 131 同位素
    • 任務
      • 與替代診斷和治療同位素的競爭
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 碘 131 同位素市場：依應用分類

  • 農業
    • 害蟲防治
    • 土壤肥力調查
  • 產業
    • 診斷
    • 放射治療
  • 藥品
    • 甲狀腺功能亢進的治療
    • 研究與開發
    • 甲狀腺癌的治療
  • 製藥
    • 放射性藥物

第 7 章 碘 131 同位素市場：依最終用戶分類

  • 農業領域
  • 醫院和診所
    • 私立醫院
    • 公立醫院
  • 製藥公司
  • 調查機構
    • 學術研究所
    • 醫學研究機構

第8章 碘 131 同位素市場：依形式

  • 膠囊
  • 氣體
  • 液體

第9章 依處理程序分類的碘 131 同位素市場

  • 放射性碘消融術
  • 放射性碘治療
  • 全身掃描

第 10 章 Iodine-131 同位素市場病患細分

  • 成人
  • 小兒科

第11章美洲碘131同位素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太碘131同位素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲碘131同位素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-9A6A6F297712

The Iodine-131 Isotope Market was valued at USD 5.20 billion in 2023, expected to reach USD 5.52 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 8.07 billion by 2030.

Iodine-131 is a radioactive isotope extensively used in medical applications, particularly for diagnostic and therapeutic purposes in nuclear medicine. It is instrumental in the treatment of thyroid disorders, such as hyperthyroidism and certain types of thyroid cancer due to its ability to destroy tissue selectively. In the energy sector, Iodine-131 is also used as a tracer in hydraulic fracturing and diagnostics of countercurrent flow. The market for Iodine-131 is driven by the increasing prevalence of thyroid disorders globally, rising awareness and adoption of nuclear medicine, and advancements in radiopharmaceutical technology. A significant influencer of growth is the heightened investment in healthcare infrastructure and expanding geriatric population prone to thyroid conditions. Moreover, increasing demand for minimally invasive procedures contributes to the market's expansion. Recent opportunities include innovations in targeted radiopharmaceutical therapies, which can broaden the application of Iodine-131 in treating other cancer types, while improving delivery mechanisms can enhance its effectiveness and reduce side effects. However, challenges like stringent regulatory frameworks, high production costs, and the necessity for specialized handling and disposal procedures due to its radioactive nature can impede growth prospects. Limitations also arise from supply chain constraints and the need for consistent quality standards in production. To capitalize on market opportunities, developing strategic collaborations between research institutions and radiopharmaceutical companies is crucial. Areas ripe for innovation include research into novel carrier molecules for Iodine-131, improving precision in dose delivery, and expanding its application scope beyond thyroid-related conditions. The market is dynamic, characterized by rapid technological advancements and evolving therapeutic demands, which together underscore the importance of sustained research investment and regulatory compliance to maintain competitive advantage and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 5.20 billion
Estimated Year [2024] USD 5.52 billion
Forecast Year [2030] USD 8.07 billion
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Iodine-131 Isotope Market

The Iodine-131 Isotope Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
    • Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
    • Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
  • Market Restraints
    • Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
  • Market Opportunities
    • Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
    • Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
    • Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
  • Market Challenges
    • Competition from alternative diagnostic and therapeutic isotopes

Porter's Five Forces: A Strategic Tool for Navigating the Iodine-131 Isotope Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Iodine-131 Isotope Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Iodine-131 Isotope Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Iodine-131 Isotope Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Iodine-131 Isotope Market

A detailed market share analysis in the Iodine-131 Isotope Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Iodine-131 Isotope Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Iodine-131 Isotope Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Iodine-131 Isotope Market

A strategic analysis of the Iodine-131 Isotope Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Iodine-131 Isotope Market, highlighting leading vendors and their innovative profiles. These include Advanced Accelerator Applications, Bayer AG, BRAHMS GmbH, Canon Medical Systems, Cardinal Health, Cardinal Health Nuclear & Precision Health Solutions, Curium, Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Isotopia Molecular Imaging, Mallinckrodt Pharmaceuticals, Medtronic, Nordion, NorthStar Medical Radioisotopes, NTP Radioisotopes, Philips Healthcare, Siemens Healthineers, Smiths Medical, and ZymoGenetics.

Market Segmentation & Coverage

This research report categorizes the Iodine-131 Isotope Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Agricultural, Industrial, Medical, and Pharmaceutical. The Agricultural is further studied across Pest Control and Soil Fertility Research. The Industrial is further studied across Diagnostics and Radiation Therapy. The Medical is further studied across Hyperthyroidism Treatment, Research and Development, and Thyroid Cancer Treatment. The Pharmaceutical is further studied across Radiopharmaceuticals.
  • Based on End User, market is studied across Agricultural Sector, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes. The Hospitals and Clinics is further studied across Private Hospitals and Public Hospitals. The Research Institutes is further studied across Academic Research Institutes and Medical Research Institutes.
  • Based on Form, market is studied across Capsules, Gas, and Liquid.
  • Based on Therapeutic Procedures, market is studied across Radioactive Iodine Ablation, Radioactive Iodine Therapy, and Whole-Body Scan.
  • Based on Patient Demographics, market is studied across Adults and Pediatrics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
      • 5.1.1.2. Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
      • 5.1.1.3. Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
      • 5.1.3.2. Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
      • 5.1.3.3. Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Competition from alternative diagnostic and therapeutic isotopes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Iodine-131 Isotope Market, by Application

  • 6.1. Introduction
  • 6.2. Agricultural
    • 6.2.1. Pest Control
    • 6.2.2. Soil Fertility Research
  • 6.3. Industrial
    • 6.3.1. Diagnostics
    • 6.3.2. Radiation Therapy
  • 6.4. Medical
    • 6.4.1. Hyperthyroidism Treatment
    • 6.4.2. Research and Development
    • 6.4.3. Thyroid Cancer Treatment
  • 6.5. Pharmaceutical
    • 6.5.1. Radiopharmaceuticals

7. Iodine-131 Isotope Market, by End User

  • 7.1. Introduction
  • 7.2. Agricultural Sector
  • 7.3. Hospitals and Clinics
    • 7.3.1. Private Hospitals
    • 7.3.2. Public Hospitals
  • 7.4. Pharmaceutical Companies
  • 7.5. Research Institutes
    • 7.5.1. Academic Research Institutes
    • 7.5.2. Medical Research Institutes

8. Iodine-131 Isotope Market, by Form

  • 8.1. Introduction
  • 8.2. Capsules
  • 8.3. Gas
  • 8.4. Liquid

9. Iodine-131 Isotope Market, by Therapeutic Procedures

  • 9.1. Introduction
  • 9.2. Radioactive Iodine Ablation
  • 9.3. Radioactive Iodine Therapy
  • 9.4. Whole-Body Scan

10. Iodine-131 Isotope Market, by Patient Demographics

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Pediatrics

11. Americas Iodine-131 Isotope Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Iodine-131 Isotope Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Iodine-131 Isotope Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

LIST OF FIGURES

  • FIGURE 1. IODINE-131 ISOTOPE MARKET RESEARCH PROCESS
  • FIGURE 2. IODINE-131 ISOTOPE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. IODINE-131 ISOTOPE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. IODINE-131 ISOTOPE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IODINE-131 ISOTOPE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IODINE-131 ISOTOPE MARKET DYNAMICS
  • TABLE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY SOIL FERTILITY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HYPERTHYROIDISM TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL SECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY WHOLE-BODY SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 270. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 272. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 281. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 283. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 292. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 294. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 303. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 305. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 314. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 316. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 323. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 324. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 325. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 327. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 328. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 329. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 330. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 331. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 332. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 333. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 334. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 335. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 336. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 338. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 339. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 340. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 341. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 343. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 344. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 345. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 346. ITALY IODINE-131 ISOTOP